Previous studies have evinced that SIRT2 is significantly correlated with CPT1A expression in metabolic diseases and that the in vitro overexpression of ketohexokinase-C (KHK-C) decreases the level of SIRT2 while promoting CPT1A acetylation (Helsley et al., 2023). This evidence concerns the gene CPT1A and metabolic disease.